APA (7th ed.) Citation

Y, K., A, I., T, Y., N, Y., D, T., Y, A., . . . Y, F. (2025). Expediting Drug Development in Japan: A PMDA Perspective. Clinical pharmacology and therapeutics, 118(6), 1262. https://doi.org/10.1002/cpt.70022

Chicago Style (17th ed.) Citation

Y, Kohno, Ishiguro A, Yasukawa T, Yasuda N, Tanaka D, Araki Y, Takahashi Y, Uyama Y, and Fujiwara Y. "Expediting Drug Development in Japan: A PMDA Perspective." Clinical Pharmacology and Therapeutics 118, no. 6 (2025): 1262. https://doi.org/10.1002/cpt.70022.

MLA (9th ed.) Citation

Y, Kohno, et al. "Expediting Drug Development in Japan: A PMDA Perspective." Clinical Pharmacology and Therapeutics, vol. 118, no. 6, 2025, p. 1262, https://doi.org/10.1002/cpt.70022.